MAPT and Alzheimer disease: Our finding might be explained by the distribution of A+ and T+ in our study sample (A+ > T+), which is to be expected considering the pathophysiological mechanism of AD development, in which the brain initially accumulates Aβ followed by a p-tau pathology.